Effectiveness of influenza vaccines in children aged 6 to 59 months: a test-negative case-control study at primary care and hospital level, Spain 2023/24.


Journal

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
ISSN: 1560-7917
Titre abrégé: Euro Surveill
Pays: Sweden
ID NLM: 100887452

Informations de publication

Date de publication:
Oct 2024
Historique:
medline: 4 10 2024
pubmed: 4 10 2024
entrez: 4 10 2024
Statut: ppublish

Résumé

During 2023/24, all children aged 6 to 59 months were targeted for seasonal influenza vaccination in Spain nationally. Using a test-negative case-control design with sentinel surveillance data, we estimated adjusted influenza vaccine effectiveness (IVE) against any influenza type to be 70% (95% confidence interval (CI): 51 to 81%) for primary care patients with acute respiratory illness (ARI) and 77% (95% CI: 21 to 93%) for hospitalised patients with severe ARI. In primary care, where most subtyped viruses (61%; 145/237) were A(H1N1), adjusted IVE was 77% (95% CI: 56 to 88%) against A(H1N1)pdm09.

Identifiants

pubmed: 39364601
doi: 10.2807/1560-7917.ES.2024.29.40.2400618
doi:

Substances chimiques

Influenza Vaccines 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Investigateurs

Alba Moya Garcés (A)
Esteban Pérez (E)
Luis García Comas (L)
Paloma Botella Rocamora (P)
Santiago Vicente Iglesias (S)
Ana Ordax Díez (A)
Lourdes Duro Gómez (L)
Mª Olga Hidalgo Pardo (MO)
Sergio Román-Soto (S)
Ana D Cebollada Gracia (AD)
Ana Fernandez Ibáñez (A)
Manuel Galán Cuesta (M)
Ninoska López Berrios (N)
Carlota Ruiz Porras (C)
Irene Pedrosa Corral (I)
Marta Pérez Abeledo (M)
Ana S Lameiras Azevedo (AS)
Sofía García Senso (S)
Virginia Álvarez Río (V)
Mª Ángel Valcárcel de Laiglesia (MÁ)
Jorge Reina Prieto (J)
Francisco J Vega-Olías (FJ)
Miriam García Vázquez (M)
Pilar Alonso Vigil (P)
Luis J Viloria Raymundo (LJ)
Paulina V Medel Jaime (PV)
Marcos Lozano (M)
Lorena Vega-Piris (L)
Silvia Galindo-Carretero (S)

Auteurs

Gloria Pérez-Gimeno (G)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
Department of Communicable Diseases, National Centre of Epidemiology, Institute of Health Carlos III, Madrid, Spain.

Clara Mazagatos (C)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
Department of Communicable Diseases, National Centre of Epidemiology, Institute of Health Carlos III, Madrid, Spain.

Nicola Lorusso (N)

Servicio de Vigilancia y Salud Laboral. Dirección General de Salud Pública y Ordenación Farmacéutica, Consejería de Salud y Consumo, Andalucía, Spain.

Luca Basile (L)

Agència de Salut Pública de Catalunya, Generalitat de Catalunya, Barcelona, Spain.

Isabel Martínez-Pino (I)

Public Health General Directorate, Castilla y León Regional Ministry of Health, Valladolid, Spain.
Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.

Francisca Corpas Burgos (F)

Subdirecció General d'Epidemiologia i Vigilància de la Salut, Direcció General de Salut Pública, Generalitat Valenciana, Valencia, Spain.

Noa Batalla Rebolla (N)

Subdirección de Epidemiología de la Dirección General de Salud Pública, Servicio Extremeño de Salud, Merida, Spain.

Mercedes B Rumayor Zarzuelo (MB)

Área de Enfermedades Transmisibles, Subdirección General de Vigilancia en Salud Pública. Dirección General de Salud Pública de la Comunidad de Madrid, Madrid, Spain.

Blanca Andreu Ivorra (B)

Servicio de Epidemiología (Sección Vigilancia Epidemiológica), Consejería de Salud- Región de Murcia, Murcia, Spain.

Jaume Giménez Duran (J)

Servicio de Epidemiologia, Consellería de Salut, Gobierno de las Islas Baleares, DGSP Baleares (IDISBA), Palma, Spain.

Daniel Castrillejo (D)

Servicio de Vigilancia Epidemiológica, Dirección General de Salud Pública, Melilla, Spain.

Inés Guiu Cañete (I)

Sección de Vigilancia Epidemiológica de la Dirección General de Salud Pública, Aragón, Spain.

Marta Huerta Huerta (M)

Dirección General de Salud Pública y Atención a la Salud Mental, Consejería de Sanidad, Principado de Asturias, Spain.

Marta García Becerril (M)

Dirección General de Salud Pública de Cantabria, Santander, Spain.

Violeta Ramos Marín (V)

Servicio de Epidemiología de la Consejería de Sanidad y Servicios Sociales de Ceuta, Ceuta, Spain.

Inmaculada Casas (I)

National Centre for Microbiology, Institute of Health Carlos III, Madrid, Spain.
Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.

Francisco Pozo (F)

National Centre for Microbiology, Institute of Health Carlos III, Madrid, Spain.
Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.

Susana Monge (S)

Consortium for Biomedical Research on Infectious Diseases (CIBERINFEC), Madrid, Spain.
Department of Communicable Diseases, National Centre of Epidemiology, Institute of Health Carlos III, Madrid, Spain.
The members of the network are listed under Collaborators.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH